NJ pharma employment down in ‘08
The number of pharma employees in New Jersey, US fell by 1,400 in 2008, with R&D expenditure, capital investment and product trials also declining, according to a report.
The number of pharma employees in New Jersey, US fell by 1,400 in 2008, with R&D expenditure, capital investment and product trials also declining, according to a report.
The growth of the Chinese vaccine market is set to outstrip the country’s pharma sector, according to a Frost & Sullivan (F&S) report that predicts 14-15 per cent CAGR.
Millipore has ramped up capacity for its Mobius range of single use bio-processing and manufacturing technologies with a new purpose built production facility in Danvers, Massachusetts.
US laboratory group Rules-Based Medicine (RBM) is aiming to improve the utility and reproducibility of biomarker analysis in drug discovery with its new DiscoveryMAP 1.0 offering.
Norwich is continuing to diversify and expand its offering by adding pilot scale production and capacity to develop high potency compounds.